49-year leukemia survivor: Why I support immunotherapy research at UT MD Anderson
I didn’t learn that Crystal Cruises was supporting UT MD Anderson’s immunotherapy research until I became a guest speaker for the cruise line in February 2026. But finding out that the company was donating a portion of its passengers’ booking fees to UT MD Anderson’s James P. Allison Institute™ through the end of 2026 was thrilling.
Why?
Because Dr. Allison won...
Liver cancer survivor thankful for immunotherapy clinical trial
When Gordon Drygalski was diagnosed with early-stage liver cancer in December 2023, several friends told him to go to UT MD Anderson for treatment...
External beam radiation therapy: How it works, what it treats and side effects
Radiation therapy is a common type of cancer treatment that uses high-energy beams to target and destroy cancer cells.
External beam...
T cell prolymphocytic leukemia (TPLL): Symptoms, diagnosis and treatment
T cell prolymphocytic leukemia (TPLL) is an extremely rare form of leukemia that affects mainly older individuals. Only about 600 people will be diagnosed with it in the U.S. in any given year. So, most physicians have never seen it.
But how does TPLL differ from other types of leukemia? Does it have any distinguishing features? What are its symptoms, and how is it treated? Are there any clinical trials available...
Why getting an accurate lymphoma diagnosis matters
If you or a loved one has been diagnosed with lymphoma, you might think all you need to know is whether it’s Hodgkin or non-Hodgkin. But is...
My brain tumor journey: Finding faith and strength at UT MD Anderson
In May 2024, I had just started my summer internship at a bank and was preparing for my senior year at Texas A&M University....
Two-time tongue cancer survivor: Why I support research at UT MD Anderson
Sometimes, the most meaningful breakthroughs in medicine aren’t about saving your life — they’re about saving your quality of life. That was...
What is a menin inhibitor?
If you or someone you know has recently been diagnosed with leukemia, you might have heard about a new treatment option called a menin inhibitor...
Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research
Joe Eastin was first diagnosed with melanoma on his left ear in 2012. The Dallas resident had surgery at home to treat the cancer and two...
Stage 4 cervical cancer survivor thankful for immunotherapy clinical trial
Looking back, Paulette Burkhart believes the fatigue she began experiencing in 2023 was not because she needed to take vitamins or get more...